Home
Obi Profile
Fees
Services
News
Publications
Contact
You are here:
Title Details
Search
Login
MELATONIN AGONIST TREATMENT
No-Receipt date
2015-01261 - 27/04/2015
No-Filing date
20150400972 - 27/04/2015
No-Granting date
3086162 - 27/05/2015
No-EPO application date
07797634.8 - 22/05/2007
No-EPO granting date
2028937 - 28/01/2015
Gazette No-Publication date of application
-
Gazette No-Publication date of granted patent
5/2015 - 18/06/2015
Expiration date
23/05/2027
Kind of title
Validation of European Patent
Legal status
NOT VALID
Priorities
US747847 P22/05/2006/US
Active Substance of Supplementary Certificates
-
IPC Classification
Ipc Class
A61P 43/00
A61K 31/405
Related Documents
Related Titles
Type
Master title
Related title
[ADD]
20180402644
Owners
Code
Firstname
Surname
Address
Town
ZIP
Country
621819
VANDA PHARMACEUTICALS INC.
2200 PENNSYLVANIA AVE NW SUITE 300-E
WASHINGTON, DC 20037, U.S.A.
UNITED STATES OF AMERICA (USA)
Inventors
Code
Firstname
Surname
1421938
BIRZNIEKS, GUNTHER
1421939
PHADKE, DEEPAK
1421940
POLYMEROPOULOS, MIHAEL, H.
Representatives
Code
Firstname
Surname
Address
Town
Zip
3335
ANDRONIKI
KIAGIA
STOURNARA 37
ATHINA (ATTIKIS)
10682
Contact
Code
Firstname
Surname
Address
Town
Zip
Country
7916
CHRISTINA-ISMINI
VAGIANOU KOSTOPOULOU
STOURNARI 37
ATHINA (ATTIKIS)
10682
GREECE
Owners History
Date
Description
Comments
Data before modification
Data after modification
01/07/2015
Αλλαγή Έδρας (7e805)
ΑΡ.ΠΡΩΤ. 3255/11-6-2015, ΚΩΔ.ΠΛΗΡ. 3089, ( ΜΕ ΤΗΝ ΥΠ'ΑΡΘ. 35549/29.04.2015, ΚΟΙΝΟΠΟΙΗΣΗ ΤΟΥ ΕΓΔΕ)
587812 Vanda Pharmaceuticals Inc. 9605 Medical Center Drive, Suite 300 ΗΝΩΜΕΝΕΣ ΠΟΛΙΤΕΙΕΣ ΤΗΣ ΑΜΕΡΙΚΗΣ Rockville NY 20850
621819 Vanda Pharmaceuticals Inc. 2200 Pennsylvania Ave Nw Suite 300-E ΗΝΩΜΕΝΕΣ ΠΟΛΙΤΕΙΕΣ ΤΗΣ ΑΜΕΡΙΚΗΣ WASHINGTON, DC 20037, U.S.A.
Title Instruments
Payments history
12 renewals have been done
© OBI all rights reserved
designed & developed by PROFILE S.A.
Certified QMS :
EN ISO 9001:2015
and
ΕΝ ISO 14001:2015
The project "Internet technological information diffusion from industrial property titles" is co-financed 70% by the European Regional Development Found and 30% by the Hellenic public sector (Operational programme "Competitiveness", Measure 4.4).